IDRI (Infectious Disease Research Institute) has been awarded a $4.4 million, five-year grant from the National Institute of Allergy and Infectious Diseases to discover sustainable alternatives to shark squalene to use as vaccine adjuvants. Funding is provided by a special bioengineering research grant aimed at bringing engineering expertise to focus on a biomedical problem and ultimately develop a new solution. Adjuvants are added to vaccines to enhance their effectiveness; the aim of the ne...